2X Blend CJC-1295 Without DAC (5mg) / Ipamorelin (5mg)
$80.00
A dual-peptide blend combining CJC-1295 Without DAC (5mg) and Ipamorelin (5mg) — two complementary growth hormone secretagogues studied for their synergistic effects on pulsatile GH release, IGF-1 stimulation, and body composition modulation in research models.
Description
A 1:1 blend by mass of CJC-1295 (No DAC) and Ipamorelin supplied for controlled research environments. This co-formulation is suitable for studies exploring GHRH-receptor and ghrelin (GHS-R1a)–receptor signaling pathways when evaluated together in model systems.
Composition
• CJC-1295 (Without DAC)
• Ipamorelin
• Appearance: Lyophilized powder in a sealed research vial
Research Focus (non-clinical)
• Comparative and combined pathway evaluation of GHRH analog + GHS agonist in in-vitro or ex-vivo models
• Assessment of assay development, including chromatographic separation of co-formulated peptides
• Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions
For qualified research professionals and institutional laboratories. Not for human use.
Documentation & Quality Assurance
Each lot is sourced through our verified global supply chain with emphasis on traceability and quality control.These documents are reviewed internally and displayed as they become available. Independent third-party testing is also performed on select lots to confirm identity, purity, and alignment with our internal specifications.
Important Notice
This product is intended for laboratory research use only. It is not intended for human or veterinary use, and must not be used for diagnostic, therapeutic, or clinical purposes.
This material is not a drug, medical device, or dietary supplement, and has not been evaluated by the U.S. Food and Drug Administration.
Quality & Manufacturing
All materials are sourced from carefully vetted domestic and international manufacturing partners who follow quality systems consistent with ISO and cGMP principles. Each supplier is reviewed for reliability, documentation integrity, and transparency in testing.
We require a verified purity of 99% or higher and perform independent third-party spot testing to confirm that select lots meet our internal standards for identity, purity, and composition. Where available, endotoxin testing results are included on Certificates of Analysis to verify laboratory purity; their inclusion is for research quality assessment only and does not imply suitability for human or veterinary use.
All research materials are sealed for integrity and packaged for stability during storage and transport from manufacturing through final delivery.
Molecular Specifications
CAS Number
Multiple (blend)
Molecular Formula
Multiple (blend)
Molecular Weight
CJC-1295 w/o DAC: 3367.97 g/mol | Ipamorelin: 711.85 g/mol
Physical Form
Lyophilized powder (co-lyophilized blend)
Storage
−20°C long-term; 2–8°C short-term
Appearance
White powder
Solubility
Soluble in sterile water
Amino Acid Sequence
CJC-1295 w/o DAC (29 AA) + Ipamorelin (5 AA)
Chain length: 34 total across both peptides amino acids
Peer-Reviewed Research
The following peer-reviewed publications represent key research on 2X Blend CJC-1295 Without DAC (5mg) / Ipamorelin (5mg) conducted in laboratory and preclinical settings.
All products sold by LGI Peptides are strictly for research use only and are not intended for human consumption or therapeutic application.
[1] CJC-1295, a long-acting growth hormone-releasing hormone analogue, stimulates growth hormone secretion
Teichman SL, et al. — Journal of Clinical Endocrinology & Metabolism, 2006
Demonstrated sustained GH and IGF-1 elevation with CJC-1295; synergistic use with Ipamorelin amplifies pulsatile GH release.
[2] Ipamorelin, the first selective growth hormone secretagogue
Raun K, et al. — European Journal of Endocrinology, 1998
Established Ipamorelin's selectivity for GH secretion without significant cortisol or prolactin elevation.
Research Use Only: All products are intended exclusively for in-vitro laboratory research.
They are not approved for human or veterinary use, consumption, or therapeutic application.
Citations are provided for informational purposes and do not constitute medical claims.
Additional information
| Weight | 0.0625 lbs |
|---|
Certificate of Analysis
Every batch undergoes independent third-party laboratory analysis to verify identity, potency, and safety. Testing includes quantitative assay verification, heavy metals screening, and comprehensive microbial analysis.
View Certificate of AnalysisStorage Instructions
All products from LGI peptides are manufactured using a lyophilization (freeze-drying) process. This method is designed to maintain product integrity and allows vials to remain stable during shipping for approximately 3–4 months.
Once a vial is reconstituted with bacteriostatic water, it should be stored in the refrigerator to help maintain stability. Under these conditions, reconstituted material is generally considered stable for up to 30 days.
Lyophilization is a dehydration technique in which compounds are frozen and then exposed to low pressure. This causes the water in the vial to sublimate directly from solid to gas, leaving behind a stable, crystalline white structure. This powder can be kept at room temperature until reconstitution.
Upon receipt, products should be stored away from heat and light. For short-term use, refrigeration at approximately 4°C (39°F) is suitable. For long-term storage (several months to years), vials may be placed in a freezer at approximately -80°C (-112°F). Freezing is the preferred method for preserving product stability over extended periods.
⚠️ Important Notice:
These products are intended for research use only. Not for human consumption.





Reviews
There are no reviews yet.